WE HAVE PREVIOUSLY SHOWN using an in vitro model that enteropathogenic Escherichia coli (EPEC) infection alters host intestinal epithelial physiological function. For example, EPEC induces the transepithelial migration of acute inflammatory cells, neutrophils (37) . The secretion of interleukin (IL)-8 from the basal aspect of infected intestinal cells in part directs neutrophil transmigration. Expression of IL-8 by intestinal epithelial cells infected with EPEC or other enteric pathogens is regulated via activation of nuclear factor (NF)-B (7, 36, 41, 45) . NF-B is an inducible transcriptional factor located in the cytoplasm and bound to inhibitory proteins that are part of the NF-B inhibitor (IB) family, i.e., IB␣, IB␤, and IB⑀ (11, 49) . There are many inducers of NF-B activation, including cytokines such as tumor necrosis factor (TNF)-␣ and IL-1␤, that trigger a cascade of events that results in IB phosphorylation. Subsequently, ubiquitin-dependent degradation of IB␣ by proteasomes (42, 46) allows the unbound NF-B to translocate to the nucleus and function as a transcriptional activator. Various signaling pathways such as elevation of intracellular Ca 2ϩ (10, 43) , mitogen-activated protein (MAP) kinases (23, 30) , protein kinase C (PKC), protein kinase A (PKA), and Raf-1 (38, 39, 43) have been reported to participate in NF-B activation. Recent publications show that specific enzymes in the extracellular signalregulated kinase (ERK) pathway such as MAP or ERK kinase kinase (MEKK)-1, -2, and -3 can directly activate the NF-B regulatory cascade (23, 29, 33, 50) .
Infection of epithelial cells with microbial pathogens also triggers various cellular signals that activate the NF-B pathway, resulting in inflammation. For example, Pseudomonas aeruginosa (25) activates NF-B via MAP kinases. Salmonella typhimurium-induced MAP kinases and elevation of intracellular Ca 2ϩ participate in the activation of NF-B and subsequent upregulation of IL-8 expression (10, 16) . Recently, Warny et al. (47) have shown that Clostridium difficile toxin A induces IL-8 expression and inflammation by stimulating p38 MAP kinase.
Previous studies have also shown that EPEC infection of intestinal epithelia disrupts barrier function. Paracellular permeability can be regulated by phosphorylation of the 20-kDa myosin light chain (MLC 20 ) located in the perijunctional cytoskeletal ring (14, 44) . We have shown that EPEC-induced perturbation of the intestinal epithelial tight junction barrier requires intracellular Ca 2ϩ and myosin light-chain kinase (MLCK) leading to MLC 20 phosphorylation (48) . Aside from Ca 2ϩ -dependent activation of MLCK, recent studies have shown that ERK can also activate this enzyme (21, 31) . The aims of this study, therefore, were to define the signaling pathways by which EPEC activates NF-B, compare them with those utilized by S. typhimurium, and determine whether these pathways are the same or divergent from those that lead to the disruption of intestinal epithelial permeability.
In this report, we show that EPEC infection of intestinal epithelial cells induces phosphorylation and degradation of IB␣ in a TNF-␣/IL-1␤ receptor-independent manner. In contrast to S. typhimurium, EPECinduced activation of NF-B and upregulated IL-8 expression do not involve Ca 2ϩ . Instead, ERK1/2 are rapidly phosphorylated and activated in intestinal epithelial cells after EPEC infection, and enzymes from this cascade are directly involved in NF-B activation and IL-8 expression. In contrast, the ERK pathway does not participate in the disruption of intestinal epithelial tight junction barrier function associated with EPEC infection.
MATERIAL AND METHODS
Cell culture. T84 cells were a generous gift from Dr. Kim Barrett (Univ. of California San Diego). Passages 35-55 were used for these studies and were grown in a 1:1 (vol/vol) mixture of Dulbecco-Vogt modified Eagle's medium (GIBCO-BRL) and Ham's F-12 (GIBCO-BRL) as described previously (28) .
Bacterial strains and infection. EPEC, wild-type strains, E2348/69, RN587/1, and S. typhimurium [American Type Culture Collection (ATTC) no. 14028, Rockville, MD] were used. EPEC strain RN587/1 is a recent clinical isolate from Brazil obtained from Dr. Michael Donnenberg (Univ. of Maryland Baltimore). Commensal E. coli strains were isolated from the stool of healthy humans by the Clinical Microbiology Laboratory at the University of Illinois (Chicago, IL) (13) . Overnight bacterial cultures, grown in Luria-Bertani broth, were diluted (1:33) in serum-and antibiotic-free tissue culture medium containing 0.5% mannose and grown at 37°C to midlog growth phase. Monolayers were infected as previously described (37) to yield a multiplicity of infection (MOI) of 100 after 1 h of infection. After infection, for the indicated time periods, medium was removed from monolayers and cells were washed three times with PBS.
Treatment with inhibitors. To define the signaling pathways involved in activation of NF-B, cells were pretreated for 1 h with select inhibitors before infection with pathogens. The MAP or ERK kinase (MEK) inhibitor PD-98059 (Calbiochem, La Jolla, CA), which at a concentration of 5 M inhibits MEK1 and at 50 M inhibits MEK2, was used. Another specific inhibitor of MEK1/2 employed for these studies was U0126 (Calbiochem) at a concentration of 0.7 M. MG-132 (Calbiochem), a proteasomal inhibitor, was used at a concentration of 50 M. Eukaryotic protein synthesis was inhibited with 2 M cycloheximide (Sigma, St. Louis, MO). We have previously reported that this concentration blocks 75% of protein synthesis in T84 cells (15) . Cellpermeant acetoxymethyl ester of 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA-AM, 15 M; Calbiochem) was used as a chelator of intracellular Ca 2ϩ as described previously by Gewirtz et al. (10) . In brief, studies were performed in Hanks' balanced salt solution (HBSS) containing 0.25 mM CaCl2, in contrast to the standard concentration of 1.25 mM CaCl 2, to maximize Ca 2ϩ chelation but preserve the monolayer barrier.
Stimulation and blockage of TNF-␣ and IL-1␤ receptors.
Cytokine-mediated pathways were stimulated by treatment of intestinal epithelial cells with TNF-␣ (10 ng/ml) or IL-1␤ (5 ng/ml). To assess IB␣ degradation, cells were treated for 15, 30, 45, and 60 min. Proteins were extracted, and the effect on IB␣ degradation was analyzed by immunoblot as described below. TNF-␣ or IL-1␤ receptor activation by their respective ligands was blocked by preincubation of cells for 1 h with blocking antibody against either the TNF-␣ (6 g/ml) or IL-1␤ receptor (1 g/ml) (R&D Systems, Minneapolis, MN). The cells were then stimulated with TNF-␣ or IL-1␤ for the indicated times. Proteins were extracted and analyzed for IB␣ degradation.
Immunoblot. Whole cell lysates from control or treated T84 cells were extracted in RIPA buffer [50 mM NaCl, 50 mM Tris, pH 7.4, 0.5% deoxycorticosterone (DOC), 0.1% NP-40, 1 mM EGTA, 1 mM Na 3VO4, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM NaF, 1 g/ml aprotinin, and 1 g/ml leupeptin]. Protein concentration was determined using a Bradford protocol, and 100 g of protein were separated by 12% SDS-PAGE. The gels were transblotted and incubated with antibodies recognizing total IB␣ (Santa Cruz Biotechnology, Santa Cruz, CA) or phosphospecific IB␣ (New England Biolabs, Beverly, MA). For ERK detection, both general (Sigma) and phosphospecific (Promega, Madison, WI) antibodies were used. Equal loading of protein was determined by probing blots for total protein-tyrosine phosphatase-1D/SH2-containing phosphatase-2 (PTP1D/SHP2) concentration (Transduction Laboratories, Lexington, KY), which does not change after EPEC infection. Color development was achieved with a nitro blue tetrazolium-5-bromo-4-chloro-indolylphosphate premixed solution (Zymed, San Francisco, CA).
ERK1/2 activity assay. For detection of ERK phosphorylation and activity, cells were serum starved overnight. After infection, proteins were extracted with 50 mM Tris, pH 7.5; 1 mM EDTA; 1 mM EGTA; 0.5 mM Na3VO4; 0.1% 2-mercaptoethanol; 1% Triton X-100; 50 mM sodium fluoride; 5 mM sodium pyrophosphate; 10 mM sodium ␤-glycerophosphate; 0.1 mM PMSF; 1 M/ml of aprotinin, pepstatin, and leupeptin; and 1 M microcystein. The immunocomplex kinase activity assay for ERK1/2 was performed according to the manufacturer's protocol (Upstate Biotechnology, Lake Placid, NY). Kinase activity was measured in a scintillation counter, and data were expressed as mean Ϯ SE increases over activity measured in uninfected monolayers. ERK activity measured in control monolayers was set at 1 to compare the results of independent assays.
Quantitation of IL-8. T84 cells were grown on 1-cm 2 Transwell filters (Costar, Cambridge, MA) coated with collagen. The cells were then infected with EPEC or treated with TNF-␣ in the presence or absence of specific inhibitors. Medium from the basolateral compartments was collected after 6 h, and IL-8 was quantified by use of a dual-antibody ELISA kit from R&D Systems, following the manufacture's protocol.
Measurement of intracellular Ca 2ϩ . T84 cells were plated on coverslips constructed to fit into standard fluorescent cuvettes. After 7 days, cells were incubated with 5 M acetoxymethyl ester of fura 2 (fura 2-AM; Calbiochem) for 1 h at 37°C and infected with EPEC for 30 min as described above. Cuvettes containing coverslips were then placed into a spectrofluorometer (Perkin Elmer, Buckinghamshire, UK) and exposed to fluorescence emission read at 505 nm while excitation wavelength was switched between 340 and 380 nm. 
where Kd is dissociation constant and R is the experimental ratio. Rmax and Rmin were measured by adding digitonin (10 M) and then EGTA (20 M), and Kd was taken to be 2.54 ϫ 10 Ϫ7 M. Electrophysiological studies. Cells were grown to confluence on 0.33-cm 2 collagen-coated permeable supports (Transwells). With the use of a simplified apparatus described by Madara et al. (27) , transepithelial electrical resistance was determined by passing 25 A of current, measuring the resulting voltage deflection, and applying Ohm's law (V ϭ IR; where V is voltage, I is current, and R is resistance).
Statistical analysis. All data are represented as the means Ϯ SE. Data comparisons were made with Student's t-test. Differences were considered significant at P Յ 0.05.
RESULTS

Infection of intestinal epithelial cells by EPEC induces phosphorylation/degradation of IB␣.
We have previously shown that the upregulation of IL-8 expression by intestinal epithelial cells in response to infection with EPEC is via activation of NF-B (36). NF-B activation is preceded by phosphorylation and degradation of the inhibitory molecule IB␣. Increased IB␣ phosphorylation was detected 15 min after infection of T84 intestinal epithelial cells with EPEC and peaked at 60 min (Fig. 1A) . By 2 h, however, this signal was absent. IB␣ degradation was detectable at 45 min postinfection and progressed until the protein was nearly absent by 2-3 h, corresponding to the loss of the phosphorylation signal. Furthermore, the proteasomal inhibitor MG-132 prevented IB␣ degradation, suggesting that EPEC stimulates this classic pathway (Fig. 1B) .
To determine whether IB␣ phosphorylation was unique to EPEC strain E2348/69, another wild-type EPEC strain, RN587/1, was tested and similar results were seen (Fig. 1C) . In contrast, nonpathogenic human commensal E. coli strains failed to elicit this change (Fig. 1D) . These findings confirm our previously published data that pathogenic but not nonpathogenic E. coli activate the NF-B pathway (13) .
Degradation of IB␣ by EPEC is independent of TNF-␣ and IL-1␤ receptor activation and de novo protein synthesis.
The best-defined pathways leading to phosphorylation and degradation of IB␣ are those initiated by activation of cytokine-specific membrane receptors, in particular TNF-␣ and IL-1␤ receptors. Infection of T84 cells by enteric bacterial pathogens has been shown to increase the expression of both TNF-␣ and IL-1␤ proinflammatory molecules (17) . We therefore sought to exclude the possibility that paracrine or autocrine responses from EPEC-stimulated TNF-␣ or IL-1␤ production could account for activation of the inflammatory cascade. Cells were preincubated with antagonistic antibodies against TNF-␣ or IL-1␤ receptors and then infected with EPEC. As shown in Fig. 2A , neither antibody prevented IB␣ degradation in response to infection. The efficiency of this approach was confirmed by demonstrating that TNF-␣-induced IB␣ degradation was prevented by pretreatment with TNF-␣ receptor blocking antibodies (Fig. 2B) . These data suggest that EPEC-activated NF-B signaling pathways in intestinal epithelial cells are TNF-␣ and IL-1␤ receptor independent and that alternative mechanisms are responsible. To define whether EPEC-induced expression of other cytokines that may secondarily activate NF-B signaling pathways was involved, cells were preincubated with cycloheximide, an inhibitor of eukaryotic protein synthesis, and infected with EPEC. Figure 2C shows that cycloheximide did not prevent EPEC-induced IB␣ degradation, suggesting that de novo protein synthesis is not required to trigger the signaling cascades by which EPEC activates inflammation-associated events.
Chelation of intracellular Ca 2ϩ has no effect on EPEC-induced IB␣ degradation or IL-8 expression. shown to increase intracellular Ca 2ϩ in eukaryotic cells (2) (3) (4) . We therefore measured the concentration of intracellular Ca 2ϩ in uninfected control T84 cells and cells infected with EPEC for 30 min. In uninfected cells, the intracellular concentration of Ca 2ϩ was determined to be 153 Ϯ 34 nM (n ϭ 9). After 30 min of infection, however, the intracellular Ca 2ϩ concentration increased to 581 Ϯ 75 nM (n ϭ 5, P ϭ 0.00004). To address whether this EPEC-induced elevation of intracellular Ca 2ϩ was involved in activation of NF-B and IL-8 expression, intestinal T84 cells were treated with the cell-permeant Ca 2ϩ chelator BAPTA-AM. Figure  3A shows that BAPTA-AM did not prevent EPECinduced IB␣ degradation or IL-8 expression (Fig. 3A) . In contrast, BAPTA-AM did block IB␣ degradation and IL-8 production in response to S. typhimurium (Fig. 3B) as was previously shown (10) . These data suggest that activation of NF-B and increased IL-8 expression by EPEC are Ca 2ϩ independent. EPEC activates ERK pathways in intestinal epithelial cells. Several bacterial pathogens have been demonstrated to induce inflammation via MAP kinase pathways (16, 18, 47) . Investigation of the impact of EPEC infection on the ERK pathway was of particular interest, since recent reports suggest that some enzymes from the ERK cascade are involved in the regulation of NF-B (30). We therefore explored whether EPEC infection triggered activation of ERK 1/2. Figure  4A shows that the amount of total ERK1/2 in T84 cells remained unchanged after EPEC infection. Equal loading of protein was determined by probing the immunoblots for total PTP1D/SHP2 protein. Immunoblots were then scanned, and densitometric analysis showed that the ratio between ERK1/2 and PTP1D/SHP2 is unchanged after infection (ϳ1:2). ERK1/2 activation by EPEC was demonstrated in two ways. First, phosphorylation of ERK1/2 increased as early as 15 min postinfection and at 30 min was fourfold higher than in uninfected control monolayers (Fig. 4A) . Correspondingly, ERK1/2 enzyme activity assays revealed a nearly fourfold peak increase at 45 min postinfection (Fig. 4B) . Infection with EPEC strain RN587/1 also induced ERK1/2 phosphorylation with a similar time course (Fig. 4C) . Human commensal E. coli strains, however, did not stimulate ERK1/2 phosphorylation (Fig. 4D) , suggesting that this is a pathogen-specific response.
EPEC-activated ERK pathways participate in IB␣ degradation and IL-8 production.
The next studies were aimed at determining whether the ERK1/2 pathway is directly involved in EPEC-induced inflammatory events. Inhibitors of specific kinases in the ERK pathway were used for these experiments: PD-98059 at 5 M was used to inhibit MEK1 and at 50 M was used to inhibit both MEK1 and -2. Both 5 and 50 M PD-98059 attenuated IB␣ degradation (Fig. 5, A and B) and IL-8 production (Fig. 5C ) associated with EPEC infection, suggesting that MEK1 and -2 are involved in this pathway. To confirm the role of ERK1/2 in EPECassociated IB␣ degradation, another MEK1/2 inhibitor, U0126, was used. Figure 5D shows that U0126 significantly suppressed EPEC-induced ERK1/2 phosphorylation and blocked the subsequent IB␣ degradation. These data support the contention that the ERK arm of the MAP kinase pathway is stimulated by EPEC infection and participates in IB␣ degradation, which ultimately leads to IL-8 expression.
ERK1/2 are not involved in EPEC-induced disruption of the tight junction barrier.
We have been shown previously that EPEC infection alters intestinal epithelial tight junction barrier function in part by phos- phorylating MLC 20 (48) . The classically described pathway by which MLCK is activated requires the formation of Ca 2ϩ -calmodulin complexes, which occurs as a result of increased intracellular Ca 2ϩ (1, 5) . The sequestration of intracellular Ca 2ϩ by dantrolene and inhibition of MLCK by 1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepene (ML-9) decreased both MLC 20 phosphorylation and the drop in transepithelial resistance (14) . More recently, however, ERK1/2 was also shown to activate MLCK, thus enhancing MLC 20 phosphorylation (21, 31) . To determine whether the ERK pathway is involved in the EPECinduced alteration of tight junction barrier function, the effect of PD-98059 on this functional consequence was tested. Figure 6 shows that neither 5 (MEK1) nor 50 M (MEK2) PD-98059 prevented the EPEC-associated disruption of barrier function as assessed by transepithelial electrical resistance. These data support the premise that EPEC-activated signaling pathways diverge and ultimately affect separate intestinal epithelial physiological functions (Fig. 6) .
DISCUSSION
EPEC infection of intestinal epithelial cells triggers two major functional effects: inflammation and disruption of barrier function. The inflammatory response is coordinated by the transcription factor NF-B. The regulation of NF-B activation is well studied, the best-defined pathway being that stimulated by cytokines. TNF-␣, for example, binds to its receptor and recruits cytoplasmic adapter molecules such as NF-Binducing kinases (NIKs) (42, 46) . NIK activates a large (ϳ800 kDa) multiprotein complex IB␣ kinase (IKK) that then phosphorylates IB␣ (42, 46) . Phosphorylated IB␣ is ubiquitinated and degraded by 26S proteasomes, freeing NF-B to translocate to the nucleus and initiate gene transcription. Enteropathogenic E. coli induces IB␣ phosphorylation/degradation in Ͻ1 h postinfection, highlighting these as early events. EPEC-stimulated NF-B activation is TNF-␣ and IL-1␤ receptor independent, does not require de novo protein synthesis, and employs pathways different from those utilized by Salmonella, suggesting that specific signals are induced by EPEC that lead to intestinal inflammation. We show here that ERK1/2, but not Ca 2ϩ , is involved in this process. Whether EPEC initiates the inflammatory cascade by direct activation of MAP kinases or utilizes NIK is not known.
There are three parallel MAP kinase cascades: ERK, c-Jun NH 2 -terminal kinase (JNK), and p38 (12, 22, 24) . Many growth factors and hormones stimulate the ERK pathway via receptor activation, whereas JNK and p38 cascades are triggered by environmental stresses. Involvement of the ERK pathway in NF-B activation has been demonstrated by showing that a dominantnegative mutant of MEKK1 inhibited NF-B activation, and overexpression of active MEKK1 resulted in the phosphorylation of IB␣ (23) . In addition, MEKK2 and -3 have been shown to activate the NF-B pathway (50) , demonstrating communication between ERK1/2 and the NF-B pathway. We show here that ERK is rapidly phosphorylated and activated after EPEC infection and that inhibition of enzymes within this pathway prevents IB␣ degradation and IL-8 production. These findings suggest that EPEC may trigger an unidentified receptor to stimulate ERK and activate NF-B. Interestingly, one of the EPEC proteins secreted by the type III secretory apparatus and injected to the host cells is the translocated intimin receptor (Tir), which serves as a receptor for the outer membrane EPEC protein intimin (6, 19) . Whether Tir-intimin interactions are required for activation of ERK has not been explored. Certainly, other receptor-ligand interactions may contribute to EPEC pathogenesis, including those that involve the bundle-forming pilus, flagellin, and perhaps type I pili. In our model system, however, the interaction of type I pili with its receptor is blocked by the addition of mannose. The role of these other potential interactions has yet to be explored. Several gastrointestinal pathogens have been shown to utilize MAP kinases to initiate inflammation. Warny et al. (47) have shown that C. difficile toxin A induces IL-8 expression and inflammation by activating p38 MAP kinases. Helicobacter pylori activates ERK, JNK, and p38, and their involvement in regulating IL-8 expression has been demonstrated (18) . Surprisingly, H. pylori-activated MAP kinases are not involved in activating NF-B, suggesting that other signaling pathways initiate the inflammatory response. In contrast, S. typhimurium activates NF-B and upregulates IL-8 production through MAP kinase cascades (16) . In this case, however, intracellular Ca 2ϩ is also involved (10) . Ca 2ϩ -dependent NF-B activation has also been demonstrated in response to other stimuli such as acetylcholine receptor ligation (10), neuropeptide substance P (26), and endoplasmic reticulum "overload" (32) . In regards to EPEC, however, Ca 2ϩ does not appear to play a role in this response, although it is involved in perturbing tight junction permeability (48) . Together these findings suggest that enteric pathogens employ different signaling pathways to induce a common response: intestinal inflammation.
EPEC stimulates other signaling molecules in intestinal epithelial cells including tyrosine kinases (34), PKC (3), reactive oxygen intermediates (35) , and inositol 1,4,5-trisphosphate (8) . The roles of these molecules in the physiological changes that occur in EPECinfected cells have not been defined. Our preliminary findings suggest that in addition to ERK1/2, these other signaling pathways may also participate in triggering the inflammatory cascade (35) . Whether these have direct effects on NF-B activation or converge on MAP kinase cascades has not been investigated. However, in other model systems, each of these signaling molecules has been shown to activate MAP kinases (40) . In addition to inducing the inflammatory response, infection with EPEC perturbs another major physiological function: intestinal epithelial permeability. Previous studies have shown that epithelial barrier function can be regulated by MLC 20 phosphorylation, which causes contraction of the perijunctional cytoskeletal ring (14) . In part, EPEC perturbs the intestinal epithelial tight junction barrier through this Ca 2ϩ / MLCK-dependent event (48) . MLCK is a Ca 2ϩ /calmodulin-dependent enzyme that phosphorylates MLC 20 (1, 5) . Recent studies show, however, that MLCK can also be activated by different stimuli. For example, urokinase-type plasminogen activator activates MLCK function by the Ras/ERK pathway (31) . Cell migration occurs via ERK-induced activation of MLCK (21) . A more recent study suggests that MAP kinases can regulate barrier function in intestinal epithelial cells by modulating the expression of claudin-2 (20), a transmembrane tight junction protein involved in barrier formation (9) . In contrast to the impact of MAP kinase inhibition on the EPEC-induced inflammatory responses, no role for these enzymes could be demonstrated with regards to EPEC-associated disruption of the tight junction barrier.
In summary, here we provide evidence that EPECinduced signaling pathways that initiate inflammation 1) are activated early and independently of TNF-␣ or IL-1␤ receptors, 2) involve ERK1/2, 3) are different from those employed by S. typhimurium, and 4) are distinct from those that disrupt paracellular permeability. This is the first demonstration that the multiple signaling cascades stimulated by EPEC infection diverge and ultimately alter distinct intestinal epithelial functions. 
